Global Immortalized Human Cells Market Growth 2024-2030

Publication ID:

LPI02259094

Publication Date:

February 20, 2025

Pages:

144

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Immortalized Human Cells market size is predicted to grow from US$ 1619 million in 2024 to US$ 2630 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.
Immortalized human cells refer to specially treated cells that can proliferate indefinitely in the laboratory without entering the aging stage. Normally, normal human cells enter a state of aging after a certain number of divisions and eventually stop dividing. However, by introducing specific genes (such as the telomerase gene) or treating them with certain chemicals, these cells are "immortalized" and can survive and reproduce for a long time in vitro culture.
United States market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Immortalized Human Cells players cover Lonza, Thermo Fisher Scientific, JSR, Valneva, Sartorius, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
The 鈥淚mmortalized Human Cells Industry Forecast鈥� looks at past sales and reviews total world Immortalized Human Cells sales in 2023, providing a comprehensive analysis by region and market sector of projected Immortalized Human Cells sales for 2024 through 2030. With Immortalized Human Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immortalized Human Cells industry.
This Insight Report provides a comprehensive analysis of the global Immortalized Human Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immortalized Human Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Immortalized Human Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immortalized Human Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immortalized Human Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of Immortalized Human Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ready-to-use
Customized
Segmentation by Application:
Medical Research
Vaccine Development
Gene Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lonza
Thermo Fisher Scientific
JSR
Valneva
Sartorius
Merck
Charles River Laboratories
Creative Bioarray
LABTOO
Cytion
EditCo
Howard Hughes Medical Institute
AcceGen
BioIVT LLC
BioCat GmbH
Cytosurge
Key Questions Addressed in this Report
What is the 10-year outlook for the global Immortalized Human Cells market?
What factors are driving Immortalized Human Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immortalized Human Cells market opportunities vary by end market size?
How does Immortalized Human Cells break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immortalized Human Cells Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immortalized Human Cells by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immortalized Human Cells by Country/Region, 2019, 2023 & 2030
2.2 Immortalized Human Cells Segment by Type
2.2.1 Ready-to-use
2.2.2 Customized
2.3 Immortalized Human Cells Sales by Type
2.3.1 Global Immortalized Human Cells Sales Market Share by Type (2019-2024)
2.3.2 Global Immortalized Human Cells Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immortalized Human Cells Sale Price by Type (2019-2024)
2.4 Immortalized Human Cells Segment by Application
2.4.1 Medical Research
2.4.2 Vaccine Development
2.4.3 Gene Therapy
2.4.4 Other
2.5 Immortalized Human Cells Sales by Application
2.5.1 Global Immortalized Human Cells Sale Market Share by Application (2019-2024)
2.5.2 Global Immortalized Human Cells Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immortalized Human Cells Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Immortalized Human Cells Breakdown Data by Company
3.1.1 Global Immortalized Human Cells Annual Sales by Company (2019-2024)
3.1.2 Global Immortalized Human Cells Sales Market Share by Company (2019-2024)
3.2 Global Immortalized Human Cells Annual Revenue by Company (2019-2024)
3.2.1 Global Immortalized Human Cells Revenue by Company (2019-2024)
3.2.2 Global Immortalized Human Cells Revenue Market Share by Company (2019-2024)
3.3 Global Immortalized Human Cells Sale Price by Company
3.4 Key Manufacturers Immortalized Human Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immortalized Human Cells Product Location Distribution
3.4.2 Players Immortalized Human Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Immortalized Human Cells by Geographic Region
4.1 World Historic Immortalized Human Cells Market Size by Geographic Region (2019-2024)
4.1.1 Global Immortalized Human Cells Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immortalized Human Cells Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immortalized Human Cells Market Size by Country/Region (2019-2024)
4.2.1 Global Immortalized Human Cells Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immortalized Human Cells Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immortalized Human Cells Sales Growth
4.4 APAC Immortalized Human Cells Sales Growth
4.5 Europe Immortalized Human Cells Sales Growth
4.6 Middle East & Africa Immortalized Human Cells Sales Growth
5 Americas
5.1 Americas Immortalized Human Cells Sales by Country
5.1.1 Americas Immortalized Human Cells Sales by Country (2019-2024)
5.1.2 Americas Immortalized Human Cells Revenue by Country (2019-2024)
5.2 Americas Immortalized Human Cells Sales by Type (2019-2024)
5.3 Americas Immortalized Human Cells Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immortalized Human Cells Sales by Region
6.1.1 APAC Immortalized Human Cells Sales by Region (2019-2024)
6.1.2 APAC Immortalized Human Cells Revenue by Region (2019-2024)
6.2 APAC Immortalized Human Cells Sales by Type (2019-2024)
6.3 APAC Immortalized Human Cells Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Immortalized Human Cells by Country
7.1.1 Europe Immortalized Human Cells Sales by Country (2019-2024)
7.1.2 Europe Immortalized Human Cells Revenue by Country (2019-2024)
7.2 Europe Immortalized Human Cells Sales by Type (2019-2024)
7.3 Europe Immortalized Human Cells Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immortalized Human Cells by Country
8.1.1 Middle East & Africa Immortalized Human Cells Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immortalized Human Cells Revenue by Country (2019-2024)
8.2 Middle East & Africa Immortalized Human Cells Sales by Type (2019-2024)
8.3 Middle East & Africa Immortalized Human Cells Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immortalized Human Cells
10.3 Manufacturing Process Analysis of Immortalized Human Cells
10.4 Industry Chain Structure of Immortalized Human Cells
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immortalized Human Cells Distributors
11.3 Immortalized Human Cells Customer
12 World Forecast Review for Immortalized Human Cells by Geographic Region
12.1 Global Immortalized Human Cells Market Size Forecast by Region
12.1.1 Global Immortalized Human Cells Forecast by Region (2025-2030)
12.1.2 Global Immortalized Human Cells Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Immortalized Human Cells Forecast by Type (2025-2030)
12.7 Global Immortalized Human Cells Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Lonza
13.1.1 Lonza Company Information
13.1.2 Lonza Immortalized Human Cells Product Portfolios and Specifications
13.1.3 Lonza Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lonza Main Business Overview
13.1.5 Lonza Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Immortalized Human Cells Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 JSR
13.3.1 JSR Company Information
13.3.2 JSR Immortalized Human Cells Product Portfolios and Specifications
13.3.3 JSR Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 JSR Main Business Overview
13.3.5 JSR Latest Developments
13.4 Valneva
13.4.1 Valneva Company Information
13.4.2 Valneva Immortalized Human Cells Product Portfolios and Specifications
13.4.3 Valneva Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Valneva Main Business Overview
13.4.5 Valneva Latest Developments
13.5 Sartorius
13.5.1 Sartorius Company Information
13.5.2 Sartorius Immortalized Human Cells Product Portfolios and Specifications
13.5.3 Sartorius Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sartorius Main Business Overview
13.5.5 Sartorius Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Immortalized Human Cells Product Portfolios and Specifications
13.6.3 Merck Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Charles River Laboratories
13.7.1 Charles River Laboratories Company Information
13.7.2 Charles River Laboratories Immortalized Human Cells Product Portfolios and Specifications
13.7.3 Charles River Laboratories Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Charles River Laboratories Main Business Overview
13.7.5 Charles River Laboratories Latest Developments
13.8 Creative Bioarray
13.8.1 Creative Bioarray Company Information
13.8.2 Creative Bioarray Immortalized Human Cells Product Portfolios and Specifications
13.8.3 Creative Bioarray Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Creative Bioarray Main Business Overview
13.8.5 Creative Bioarray Latest Developments
13.9 LABTOO
13.9.1 LABTOO Company Information
13.9.2 LABTOO Immortalized Human Cells Product Portfolios and Specifications
13.9.3 LABTOO Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 LABTOO Main Business Overview
13.9.5 LABTOO Latest Developments
13.10 Cytion
13.10.1 Cytion Company Information
13.10.2 Cytion Immortalized Human Cells Product Portfolios and Specifications
13.10.3 Cytion Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Cytion Main Business Overview
13.10.5 Cytion Latest Developments
13.11 EditCo
13.11.1 EditCo Company Information
13.11.2 EditCo Immortalized Human Cells Product Portfolios and Specifications
13.11.3 EditCo Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 EditCo Main Business Overview
13.11.5 EditCo Latest Developments
13.12 Howard Hughes Medical Institute
13.12.1 Howard Hughes Medical Institute Company Information
13.12.2 Howard Hughes Medical Institute Immortalized Human Cells Product Portfolios and Specifications
13.12.3 Howard Hughes Medical Institute Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Howard Hughes Medical Institute Main Business Overview
13.12.5 Howard Hughes Medical Institute Latest Developments
13.13 AcceGen
13.13.1 AcceGen Company Information
13.13.2 AcceGen Immortalized Human Cells Product Portfolios and Specifications
13.13.3 AcceGen Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 AcceGen Main Business Overview
13.13.5 AcceGen Latest Developments
13.14 BioIVT LLC
13.14.1 BioIVT LLC Company Information
13.14.2 BioIVT LLC Immortalized Human Cells Product Portfolios and Specifications
13.14.3 BioIVT LLC Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioIVT LLC Main Business Overview
13.14.5 BioIVT LLC Latest Developments
13.15 BioCat GmbH
13.15.1 BioCat GmbH Company Information
13.15.2 BioCat GmbH Immortalized Human Cells Product Portfolios and Specifications
13.15.3 BioCat GmbH Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 BioCat GmbH Main Business Overview
13.15.5 BioCat GmbH Latest Developments
13.16 Cytosurge
13.16.1 Cytosurge Company Information
13.16.2 Cytosurge Immortalized Human Cells Product Portfolios and Specifications
13.16.3 Cytosurge Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Cytosurge Main Business Overview
13.16.5 Cytosurge Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂